Los Angeles-based ReNAD+ (+1-310-564-7994), a new alternative to traditional drug rehabilitation options, has updated its treatments to stop withdrawals and cravings for patients in Santa Ana, California, detoxing from fentanyl, Xanax, and alcohol.
—
For decades, there have been a few standard options for patients attempting to detox and overcome past substance abuse issues, but they all suffered from the same major flaw. ReNAD+ offers a new alternative that uses NAD+ IV therapy to prevent the unpleasant symptoms of withdrawal and reduce cravings.
More information about NAD+ IV therapy, preventing withdrawal symptoms, and ReNAD+ can be found at https://nadtreatment.com
The traditional method for detoxing is simple. Patients only have to wait and the drugs will slowly, and often painfully, leave their system. As part of its expanded therapy, ReNAD+ takes a different approach by manually flushing out any drugs that remain in a patient’s body, and restoring their cell’s depleted levels of NAD.
NAD, or nicotinamide adenine dinucleotide, occurs naturally in all living cells and plays a vital role in keeping them healthy. Unfortunately, cells can become deficient in NAD in several ways, including due to certain diseases, old age, and long-term substance abuse.
The NAD therapy offered by ReNAD+ gently replaces the body’s lost NAD, which helps to restore mitochondria, provide additional energy at the cellular level, and repair damaged DNA. It has also been shown in several extensive studies to reduce the withdrawal symptoms associated with detoxing from drugs, such as fentanyl, Xanax, and alcohol.
In a recent study, NAD therapy was found to have a 90% success rate at eliminating withdrawal symptoms, making it significantly easier for patients to recover from sustained substance abuse. When surveyed, 92% of patients said they had little to no withdrawal symptoms or cravings for drugs.
In traditional treatment settings, such as drug rehabilitation centers and 12-step programs, success rates average around 50%, if patients who relapse but return to try again are included as successes. A recent study with NAD treatment found that only 2 out of 60 patients relapsed in the first 14 months, giving it a success rate of 96.6%.
One satisfied client said, “ReNAD+ was the perfect combination of compassion and results. Their dedication to NAD + IV’s and pure passion in modern medicine will change many lives.”
More information about ReNAD+, NAD IV therapy and supporting studies can be found at https://nadtreatment.com
Contact Info:
Name: Luke Dandrea
Email: Send Email
Organization: ReNAD+
Address: 601 11th ave , San Diego, CA 92101, United States
Website: https://nadtreatment.com/
Source: PressCable
Release ID: 89084814
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 8 hours.
